News Conference News AHA 2024 Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression Yael L. Maxwell November 20, 2024
News Conference News AHA 2024 ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH Caitlin E. Cox November 18, 2024
News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
News Conference News HFSA 2024 Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM L.A. McKeown October 04, 2024
News Conference News HFSA 2024 ‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF Michael O'Riordan October 03, 2024
News Daily News New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery Michael O'Riordan September 24, 2024
News Conference News ESC 2024 AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions Caitlin E. Cox September 12, 2024
News Daily News Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs L.A. McKeown August 15, 2024
News Daily News CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI Yael L. Maxwell July 18, 2024
News Industry News CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction May 29, 2024
News Daily News Certain Periprocedural MIs Don’t Matter, New Data Allege Michael O'Riordan May 09, 2024
News Daily News Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift Yael L. Maxwell May 03, 2024
News Conference News ACC 2024 Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI Michael O'Riordan April 07, 2024
News Daily News ACC Chest Pain Pathway Performs Well Overall, Less So for Those With CAD Yael L. Maxwell March 28, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024